AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database

Clinical trial NCT06548152 · RECRUITING

Trial details

NCT number: NCT06548152
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2025-04-28
Primary completion: 2026-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.